Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
addressed, adversary, al, annotated, APIC, ASC, ASU, begun, Biomed, Cadwalader, carefully, chest, China, consolidted, counsel, Creek, Cyganowski, depleted, depletion, Doctor, Doug, Duke, emboli, enrichment, enterprise, ERP, fresh, Fuqua, gould, holdback, immaterial, indemnity, indirect, ineffective, inspector, Jersey, kevin, laporte, lean, network, nontaxable, owed, penalty, Polytechnic, pool, realignment, Rensselaer, repay, resource, restraining, revaluation, save, Sherk, shut, steven, streamline, sublimit, swingline, Taft, TermLoan, Terumo, thrombi, Toronto, Trowbridge, unclear, unconditionally, understood, unfair, unjust, upper, USPTO, verification, verified, Walnut, Wickersham
Removed:
adjustable, Allergan, allocation, amounted, Bolton, Chairman, chose, collaborate, collateralized, conform, consecutive, creation, declaratory, deliverable, document, Education, enforce, essentially, establishment, excellent, flat, formation, function, GB, great, industrial, inInternal, Installment, Job, Keybanc, launching, loyalty, McGill, member, mortgage, Multimode, play, qualitative, quantitative, Reauthorization, Registrar, reinvested, relevant, reportable, slower, software, St, stipulation, Stryker, suffering, unforeseen, unlimited, Warren, Washington
Filing tables
Filing exhibits
Related press release
ANGO similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (No. 333-190642) and on Form S-8 (No 333-120057, No. 333-138456, No. 333-140627, No. 333-161355, No. 333-162844, No. 333-170619 and No. 333-190640) of AngioDynamics, Inc. of our report dated August 14, 2014 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Albany, New York
August 14, 2014